A variety of GTP-binding protein (G protein)-coupled receptors are expressed at the nerve terminals of central synapses and play modulatory roles in transmitter release. At the calyx of Held, a rat auditory brainstem synapse, activation of presynaptic ␥-aminobutyric acid type B receptors (GABAB receptors) or metabotropic glutamate receptors inhibits presynaptic P͞Q-type Ca 2؉ channel currents via activation of G proteins, thereby attenuating transmitter release. To identify the heterotrimeric G protein subunits involved in this presynaptic inhibition, we loaded G protein ␤␥ subunits (G␤␥) directly into the calyceal nerve terminal through whole-cell patch pipettes. G␤␥ slowed the activation of presynaptic Ca 2؉ currents (IpCa) and attenuated its amplitude in a manner similar to the externally applied baclofen, a GABAB receptor agonist. The effects of both G␤␥ and baclofen were relieved after strong depolarization of the nerve terminal. In addition, G␤␥ partially occluded the inhibitory effect of baclofen on IpCa. In contrast, guanosine 5-O-(3-thiotriphosphate)-bound Go␣ loaded into the calyx had no effect. Immunocytochemical examination revealed that the subtype of G proteins Go, but not the Gi, subtype, is expressed in the calyceal nerve terminal. These results suggest that presynaptic inhibition mediated by G protein-coupled receptors occurs primarily by means of the direct interaction of Go ␤␥ subunits with presynaptic Ca 2؉ channels.
I
n the central nervous system, synaptic transmission is regulated by presynaptic autoreceptors or heteroreceptors. These receptors are coupled by G proteins to various targets such as Ca 2ϩ channels, K ϩ channels, or the exocytotic machinery downstream of Ca 2ϩ influx (1) . At a rat brainstem auditory synapse formed by a giant nerve terminal, the calyx of Held, metabotropic glutamate receptors (mGluRs), or ␥-aminobutyric acid type B receptors (GABA B receptors) primarily inhibit P͞Q-type Ca 2ϩ channels (2) (3) (4) . The inhibitory effect of the GABA B receptor agonist baclofen on presynaptic Ca 2ϩ currents can be blocked by the GDP analog guanosine 5Ј-O-(2-thiodiphosphate) (GDP [␤S] ) and occluded by the nonhydrolyzable GTP analog guanosine 5Ј-O-(3-thiotriphosphate) (GTP[␥S]), both loaded directly into the calyx, indicating that G proteins mediate the presynaptic inhibition (3) . At the cell soma, heterotrimeric G proteins attenuate Ca 2ϩ currents acting either directly via a membrane-delimited pathway involving G protein ␤␥ subunits (G␤␥) or indirectly via second messengers (5, 6) . At the nerve terminal, however, it is not known which mechanism underlies this presynaptic inhibition. At the calyx of Held, which can be visually identified in slice, it is possible to load various molecules into the nerve terminal through whole-cell recording pipette (3, 7, 8) . Using this technique, we examined the effect of G␤␥ on I pCa . Also, because of its large structure, it was possible to use immunocytochemistry to determine the subtype of G proteins expressed in the calyceal nerve terminal. Our results suggest that the ␤␥ subunits of G o mediate the presynaptic inhibition at the calyx of Held synapse by directly interacting with presynaptic Ca 2ϩ channels.
Methods Preparations and Solutions.
All experiments were performed in accordance with the guidelines of the Physiological Society of Japan. Wistar rats (12-17 days old) were killed by decapitation under halothane anesthesia. The whole brain was immersed in an ice-cold cutting solution containing 250 mM sucrose, 2.5 mM KCl, 26 mM NaHCO 3 , 10 mM glucose, 1.25 mM NaH 2 PO 4 , 1 mM CaCl 2 , 4 mM MgCl 2 , 0.5 mM myo-inositol, 2 mM sodium pyruvate, and 0.5 mM ascorbate, pH 7.4, when saturated with 95% O 2 ͞5% CO 2 . A tissue block containing the brainstem and cerebellum was removed and glued onto the stage of a tissue slicer (Microslicer DTK-1000, Dosaka, Kyoto, Japan) and immersed in the cutting solution. Transverse slices (150 m in thickness) containing the medial nucleus of the trapezoid body (MNTB) were cut and incubated at 36°C for 1 h in the artificial cerebrospinal fluid containing 125 mM NaCl, 2.5 mM KCl, 26 mM NaHCO 3 , 10 mM glucose, 1.25 mM NaH 2 PO 4 , 2 mM CaCl 2 , 1 mM MgCl 2 , 0.5 mM myo-inositol, 2 mM sodium pyruvate, 0.5 mM ascorbate, pH 7.4, when saturated with 95% O 2 ͞5% CO 2 .
Recording and Data Analysis. For electrophysiological recordings, one slice was transferred to a superfusing chamber on a stage of upright microscope (Axioskop, Zeiss), and individual calyces in the MNTB were visualized with a 40ϫ water-immersion objective lens (Zeiss) through a charge-coupled device camera. The recording chamber was continuously superfused with the artificial cerebrospinal fluid. Whole-cell presynaptic Ca 2ϩ currents were recorded from calyces under voltage clamp being evoked with depolarizing steps from a holding potential of Ϫ80 mV. To isolate Ca 2ϩ currents, 10 mM tetraethylammonium chloride and 1 M tetrodotoxin were included in the artificial cerebrospinal fluid, and the presynaptic patch pipette was filled with a solution containing 110 mM CsCl, 40 mM Hepes, 0.5 mM EGTA, 1 mM MgCl 2 , 2 mM ATP, 0.5 mM GTP, 12 mM disodium phosphocreatine, and 10 mM tetraethylammonium chloride, with pH adjusted to 7.4 with CsOH. The electrode resistance was 5-10 M⍀, and series resistance was typically 10-30 M⍀ and compensated by 70-80%. Whole-cell current recordings were made by using a patch-clamp amplifier (Axopatch 200B, Axon Instruments, Foster City, CA). Records were low-pass filtered at 2 kHz and digitized at 5 kHz with a CED 1401 interface (Cambridge Electric Design). Leak currents were subtracted for presynaptic currents by a scaled pulse divided by n (P͞N) protocol (3). Statistical significance was evaluated by paired t test unless otherwise noted. The liquid junction potential between the internal and external solutions was not corrected for. (3-thiotriphosphate) ; G␤␥, G protein ␤␥ subunits; MNTB, medial nucleus of the trapezoid body; GIRK, G protein-activated inwardly rectifying potassium current; mGluR, metabotropic glutamate receptor.
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(G o ␣) were from Calbiochem. G␤␥ was dissolved at 50 g͞ml in 50 mM Hepes͞1 mM DTT͞1 mM EDTA͞0.1% (1.25 M) Lubrol, pH 7.6, and stored at Ϫ80°C. S] was 100 nM (total amount of G o ␣ was 250 nM). The concentration of free GTP[␥S] remaining after gel filtration was estimated to be less than 0.12 nM. G protein subunits were applied through whole-cell pipettes into calyces by diffusion. Baclofen (2 or 20 M) was bath-applied by switching superfusates by using solenoid valves. Experiments were carried out at room temperature (24-27°C).
Immunocytochemistry. Wistar rats (13-15 days old) were anesthetized with Nembutal and transcardially perfused with a fixative (4% paraformaldehyde and 0.2% picric acid in 0.1 M sodium phosphate, pH 7.4). After fixation, rats were killed by decapitation, and a tissue block of brainstem including the MNTB region was removed for postfixation for 1-2 days at 4°C. The fixed tissue was cryoprotected at 4°C in 0.1 M sodium phosphate with sucrose of graded concentrations: in 4% sucrose for 30 min, 10% for 2 h, 15% for 2 h, and 20% overnight. Transverse slices (25 m in thickness) were cut with a cryostat (CM3050, Leica, Nussloch, Germany) at Ϫ21°C. The sections were then processed for immunocytochemistry as follows: (i) blocking and permeabilization in phosphate-buffer saline solution containing 4% skim milk and 0.3% (wt͞vol) Triton X-100 for 5 h; (ii) application of primary antibodies in PBS containing 0.5% (wt͞vol) BSA and 0.05% Triton X-100 for 2 days at 4°C; (iii) application of secondary antibodies in the same buffer as primary antibodies for overnight at 4°C; and (iv) mounting with ProLong antifade kit (Molecular Probes). The primary antibodies were rabbit polyclonal anti-G o ␣ subunit, anti-G o ␣ and G i ␣3 subunits, anti-G i ␣1 and G i ␣2 subunits, anti-G i ␣3 subunit (Calbiochem), and mouse monoclonal anti-synapsin I (Chemicon) diluted 1:100. The secondary antibodies were anti-mouse IgG conjugated with Alexa fluor 568 and anti-rabbit IgG conjugated with Alexa fluor 488 (Molecular Probes, diluted 1:200). Stained sections were viewed with a 100ϫ oil-immersion objective (numerical aperture 1.35) or 100ϫ water-immersion objective (numerical aperture 1.0) using a confocal laser scanning microscope (Fluoview FV300, Olympus Optical, Tokyo). Excitation wavelengths were 488 nm (argon laser) and 543 nm (He͞Ne laser). Emission wavelengths were 510-530 nm (for green) and Ͼ610 nm (for red). All of the immunocytochemical procedures were carried out at room temperature (22-27°C) unless otherwise noted.
Results
Inhibitory Effect of G␤␥ on Presynaptic Ca 2؉ Currents. To examine the effect of G␤␥ on I pCa , we loaded G␤␥ (100 nM) directly into the calyceal nerve terminal through a whole-cell patch pipette by passive diffusion. After rupture of patch membrane, I pCa was evoked by a depolarizing pulse (10 ms) from a holding potential of Ϫ80 mV (Fig. 1) . At the calyx of Held at this postnatal age (12-17 days old), I pCa has been pharmacologically characterized as the P͞Q type (9, 10) . After rupture with a pipette containing G␤␥, the activation rate of I pCa gradually became slower and its amplitude smaller (measured 2.5 ms after the onset of pulse).
The slowness of the effects of G␤␥ might, at least in part, be due to a slow rate of diffusion of G␤␥ (about 40 kDa) into the calyx. The mean amplitude of I pCa 25 min after rupture was 65.4 Ϯ 3.1% (n ϭ 3) of the amplitude measured 5 min after rupture. In contrast, no appreciable change was observed for I pCa when G␤␥ inactivated by boiling (100 nM) was loaded into calyces (96.2 Ϯ 4.0%, n ϭ 3). Thus, G␤␥ specifically and significantly inhibited I pCa (P Ͻ 0.005, unpaired t test). This effect of G␤␥ is similar to that obtained by externally applying the GABA B agonist baclofen (3, 4) , the mGluR agonist L-2-amino-4-phosphonobutyrate (2) 
or by intracellularly infusing GTP[␥S] (3, 7).
Depolarization-Induced Unblock of IpCa Inhibitions by G␤␥ and Baclofen. Inhibition of voltage-dependent Ca 2ϩ channels by G i or G o takes place via a membrane-delimited pathway and is transiently disinhibited after strong depolarization (11, 12) . We examined whether this disinhibition might be observed for the effects of G␤␥ on I pCa (Fig. 2) . First, we evoked a series of I pCa by using 10-mV incremental depolarizing step pulses of a 10-ms duration to formulate a current-voltage relationship (9) . We then applied a large conditioning depolarizing pulse (to ϩ100 mV, 10-ms duration) and followed this with the same series of test pulses. When G␤␥ (200 nM) was present in the recording pipette, the conditioning pulse increased the activation rate and amplitude of I pCa for a wide range of test potentials (Fig. 2 A, significant differences at Ϫ20 mV and Ϫ10 mV, P Ͻ 0.02, n ϭ 6 cells). The peak of I pCa in the current-voltage relationship showed a concomitant shift by about Ϫ10 mV, indicating that gating of the Ca 2ϩ channels had shifted toward the ''willing'' state (13) . Similar effects were observed when baclofen (20 M) was present in the superfusate (Fig. 2C) , as previously reported (4). In contrast, no such disinhibition was observed when boiled G␤␥ (200 nM) was present in the recording pipette (Fig. 2B , n ϭ Occlusion of G␤␥ with Baclofen in the Inhibitory Effect on IpCa. If G␤␥ mediates the baclofen-induced inhibition of I pCa , intracellular loading of G␤␥ would be expected to occlude the effect of baclofen. In the presence of G␤␥ in the presynaptic pipette (200 nM), the first application of baclofen (2 M) just after rupture (Ͻ6 min) clearly inhibited I pCa (Fig. 3A) . However, the second application of baclofen 15-20 min later inhibited I pCa amplitude to a significantly lesser extent (66 Ϯ 0.4%, n ϭ 8, P Ͻ 0.00002). In contrast, when heat-inactivated G␤␥ was included in the presynaptic patch pipette, the second application of baclofen inhibited I pCa to a similar extent as the first application (Fig. 2B , 94 Ϯ 3%, n ϭ 7, P Ͼ 0.1). Thus, G␤␥ occluded the inhibitory effect of baclofen on I pCa . The occluding effect of G␤␥ on baclofen-induced inhibition of I pCa was weaker than that obtained with GTP[␥S] (3). This may be due to insufficient presynaptic concentrations of G␤␥ because of its slow diffusion, inadequate conditions for its full potency, or the involvement of additional subunits or second messengers.
Effects of Go␣ on IpCa. We examined whether G o ␣ subunits are also involved in the baclofen-induced presynaptic inhibition by loading calyces with constitutively active G o ␣ containing bound GTP [␥S] . In the presence of G o ␣-GTP[␥S] in the presynaptic whole-cell pipette (100 nM), I pCa remained unchanged for at Boiled G␤␥ had no effect (B). (C) Go␣-GTP[␥S] included in the presynaptic pipette (100 nM; total G o␣, 250 nM) had no effect on the baclofen-induced IpCa inhibition.
least 40 min after rupture, and the first and second applications of baclofen (2 M), separated by 15-to 20-min intervals, inhibited I pCa to similar extents (Fig. 3C, 103 Ϯ 4 .8%, n ϭ 5, P Ͼ 0.5). G o ␣-GTP [␥S] has been reported to be effective in attenuating Ca 2ϩ currents in chick dorsal rot ganglia in culture at lower concentrations (Ͻ20 nM) (14) . Thus, G o ␣ does not seem to mediate baclofen-induced I pCa inhibition.
Effects of Cyclic Nucleotides on the Baclofen-Induced IpCa Inhibition.
Our present results are consistent with a membrane-delimited, G protein-dependent mechanism for the baclofen effect. However, it has been reported that cyclic (c) GMP is responsible for mGluR-mediated presynaptic inhibition (15) and somatostatininduced inhibition of Ca 2ϩ currents (16). We examined further the possible contribution of adenylyl cyclase or guanylyl cyclase to presynaptic inhibition by loading calyces with cAMP or cGMP at high concentrations (200 M). This concentration of cyclic nucleotides is three orders of magnitude higher than their resting concentrations (17) . In the presence of 200 M cAMP, baclofen (20 M) attenuated I pCa by 37.7 Ϯ 3.5% (n ϭ 4). Similarly, in the presence of 200 M cGMP, baclofen attenuated I pCa by 39.5 Ϯ 2.8% (n ϭ 5). The magnitudes of inhibition of I pCa by baclofen are comparable with that observed in their absence (38.0 Ϯ 3.8%, n ϭ 6). These results suggest that the presynaptic inhibitory effect of baclofen is mediated mainly by a membrane-delimited pathway, rather than via intracellular cyclic nucleotides.
Effects of Botulinum Toxin C1 on the Baclofen-Induced IpCa Inhibition.
It has been reported that cleaving syntaxin 1A with botulinum toxin C1 blocks (18) or attenuates (19) G protein modulation of N-type Ca 2ϩ channels. We examined whether botulinum toxin C1 might affect the baclofen-induced inhibition of I pCa . Preincubation of slices with botulinum toxin C1 (332 nM) for 3-4 h had no significant effect on the magnitude of inhibition of I pCa by baclofen (20 M, 31.8 Ϯ 5.6%, n ϭ 6, data not shown). When botulinum toxin C1 was included in whole-cell pipette (286 nM), no appreciable change was observed for the amplitude and kinetics of I pCa , and baclofen inhibited I pCa to a similar extent for at least 40 min after rupture. Thus, it remains undetermined whether syntaxin plays a role in G protein modulation of presynaptic P͞Q-type Ca 2ϩ channels.
Presence of G Proteins at the Calyx of Held Nerve
Terminal. Baclofeninduced presynaptic inhibition can be blocked by externally applied N-ethylmaleimide (4) . When N-ethylmaleimide (1 mM) was included in pipettes, baclofen (20 M) only marginally inhibited I pCa (by 5.2 Ϯ 1.2%, n ϭ 4, data not shown). These suggest that the G i or G o mediates the presynaptic inhibitory effect of baclofen. However, it is not known which type of G protein is expressed at the nerve terminal. The large size of this nerve terminal is advantageous for the immunocytochemical identification of the presynaptic molecules expressed there. We stained the calyces with antibodies specific for different G protein subtypes together with antibody against synapsin I as a nerve terminal marker. As shown in Fig. 4A , an antibody that binds both G o ␣ and G i ␣3 stained calyces and postsynaptic MNTB cells, with its immunofluorescence substantially overlapped with that of an anti-synapsin I antibody. By contrast, an antibody specific for G i ␣3 stained mainly postsynaptic MNTB cells, with little overlap with the synapsin immunoreactivity (Fig.  4B) . Similarly, antibody that recognizes both G i ␣1 and G i ␣2 stained only the postsynaptic cells sparing calyces (Fig. 4C) . In contrast, an antibody specific for G o ␣ clearly stained both calyces and postsynaptic cells (Fig. 4D) . These results indicate that the main G i family protein expressed at the calyx of Held nerve terminal is the G o subtype, whereas both G i and G o are expressed at the postsynaptic MNTB cell.
Discussion
The observation that GABA depresses Ca 2ϩ currents in chick dorsal root ganglion cells suggested that a similar mechanism might operate at the nerve terminal (20) . Subsequent studies have been carried out on transmitter-induced modulation of Ca 2ϩ channels expressed in the cell soma. In soma of sympathetic neurons, a membrane-delimited mechanism was shown to be the major pathway for the inhibition of N-type Ca 2ϩ channel currents by heterotrimeric G proteins (5) . In experiments using overexpressed G␤␥ (21-24), G␤␥-binding peptide (23, 25) , or G␣ (26) in culture cells, this mechanism has been shown to involve G␤␥ subunits. Similarly, in culture cells, recombinant P͞Q-type Ca 2ϩ channel currents can be attenuated by injection or overexpression of G␤␥ subunits (21) , and their inhibition by GTP [␥S] can be reversed by G␤␥-binding peptides (27) . Despite the wealth of information accumulated on somatic Ca 2ϩ currents, there had been no direct evidence indicating that subunits of heterotrimeric G proteins attenuate presynaptic Ca 2ϩ currents. In the present study, we loaded heterotrimeric G protein subunits directly into a mammalian giant nerve terminal, the calyx of Held, and demonstrated that G␤␥ attenuates presynaptic Ca 2ϩ currents. GTP[␥S]-bound G o ␣ subunit similarly loaded into the nerve terminal had no effect. This effect of G␤␥ mimicked and occluded the effects of the GABA B receptor agonist baclofen. At this synapse, baclofen inhibits presynaptic Ca 2ϩ currents (3, 4) , and this effect fully explains its inhibitory effect on transmitter release (3), despite other mechanisms postulated at other synapses (1). Our present results indicate that presynaptic inhibition via GABA B receptor is mediated mainly by G␤␥ at this mammalian central synapse.
At the calyx-type nerve terminal in chick ciliary ganglia, both the G o and G i subclasses are expressed together with other G proteins (28) . Surprisingly, however, the calyx of Held terminal expressed only G o , whereas the postsynaptic cell expressed both G o and G i . These results suggest that GABA B receptors are coupled with G o ␣ (but not G i ␣) and that its partner, G o ␤␥, inhibits presynaptic P͞Q-type Ca 2ϩ channels at this synapse. This is consistent with the hypothesis that G o -type G proteins (but not G i -type) are involved in the membrane-delimited inhibition of Ca 2ϩ currents (29) (30) (31) . It has been reported that G i ␣ (not G o ␣) inhibits adenylyl cyclase (6). Our results also indicate that cyclic nucleotides are not involved in the baclofen-induced inhibition of presynaptic Ca 2ϩ currents. It has previously been reported that G i (but not G o ) activates the G protein-activated inwardly rectifying potassium current (GIRK) (32 An involvement of a phospholipase C-dependent pathway has been suggested for the inhibition of P͞Q-type Ca 2ϩ currents by mGluR7 in cerebellar granule cell soma (33) . The calyx of Held terminal expresses mGluR4 and also mGluR7 at later stages of development (34) , and presynaptic inhibition by an mGluR agonist is mediated by inhibition of presynaptic P͞Q-type Ca 2ϩ currents (2) . This effect of mGluR agonist can be completely occluded by baclofen (Y.K. and T.T., unpublished observation), suggesting that the presynaptic inhibitory mechanism via mGluRs and GABA B receptors may be identical. Also, at this synapse, activation of protein kinase C by phorbol ester has no effect on presynaptic Ca 2ϩ currents (8) . Thus, the G o ␤␥ seems to play essential roles in autoreceptor-and heteroreceptormediated presynaptic inhibition at the calyx of Held synapse. At this synapse, a general block of G protein activity using GDP [␤S] slows the rate of recovery from activity-dependent synaptic depression by blocking vesicle trafficking (7) . It remains to be seen whether G o ␤␥ is involved in the vesicular replenishment at this mammalian nerve terminal.
Inhibition of Ca 2ϩ currents by G proteins is characterized by a slowing in the rate of activation and the relief of inhibition following large depolarization, which has been explained by proposing a shift of Ca 2ϩ channel gating between ''reluctant'' and ''willing'' states (13) . These properties were also observed for the inhibitory effects of G␤␥ and baclofen on presynaptic P͞Q-type Ca 2ϩ currents. It is possible that presynaptic inhibition by means of G protein-coupled receptors is relieved during high-frequency transmission because of presynaptic action potentials (35) . At the calyx of Held synapse, presynaptic Ca 2ϩ currents undergo facilitation during repetitive activation (36, 37) . This facilitation depends on Ca 2ϩ influx and can be induced by a 1-ms depolarizing conditioning pulse from Ϫ80 mV to Ϫ10 mV but is not affected by GDP [␤S] or GTP [␥S] , excluding an involvement of G proteins in its mechanism (36) . In fact, much stronger depolarization is required for relieving I pCa from G protein-dependent inhibition. Thus, the physiological significance of the depolarization-induced relief of Ca 2ϩ currents from G protein-dependent inhibition remains to be determined.
